[How I treat acute graft versus host disease].
作者信息
Xu L P, Huang X J
机构信息
Peking Universi-ty, People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2017 Aug 14;38(8):649-655. doi: 10.3760/cma.j.issn.0253-2727.2017.08.001.
Abstract
摘要
相似文献
1
[How I treat acute graft versus host disease].[我如何治疗急性移植物抗宿主病]
Zhonghua Xue Ye Xue Za Zhi. 2017 Aug 14;38(8):649-655. doi: 10.3760/cma.j.issn.0253-2727.2017.08.001.
2
SupplAzithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial.补充阿奇霉素预防移植物抗宿主病：一项随机安慰剂对照试验
Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):77-83.
3
High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.无关供者骨髓移植中严重急性移植物抗宿主病和死亡的高风险HLA等位基因
Haematologica. 2016 Apr;101(4):491-8. doi: 10.3324/haematol.2015.136903. Epub 2016 Jan 14.
4
Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid.肠急性移植物抗宿主病中的 Amphiregulin：一种可能的诊断和预后辅助手段。
Mod Pathol. 2019 Apr;32(4):560-567. doi: 10.1038/s41379-018-0170-z. Epub 2018 Nov 13.
5
Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation.异体造血干细胞移植后，故意供体淋巴细胞诱导的局限性急性移植物抗宿主病对于复发急性髓系白血病的长期生存至关重要。
Haematologica. 2014 Apr;99(4):751-8. doi: 10.3324/haematol.2013.089565. Epub 2013 Nov 15.
6
Improved survival after acute graft--host disease diagnosis in the modern era.现代急性移植物抗宿主病诊断后的生存率提高。
Haematologica. 2017 May;102(5):958-966. doi: 10.3324/haematol.2016.156356. Epub 2017 Mar 16.
7
Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease.去甲肾上腺素的血浆水平和β2 - 肾上腺素能受体基因的表达水平与急性移植物抗宿主病的发生率相关。
Med J Islam Repub Iran. 2020 Nov 9;34:151. doi: 10.34171/mjiri.34.151. eCollection 2020.
8
Upper gastrointestinal acute graft--host disease adds minimal prognostic value in isolation or with other graft--host disease symptoms as currently diagnosed and treated.上消化道急性移植物抗宿主病在目前的诊断和治疗中，单独或与其他移植物抗宿主病症状一起，增加的预后价值极小。
Haematologica. 2018 Oct;103(10):1708-1719. doi: 10.3324/haematol.2017.182550. Epub 2018 Aug 3.
9
Acute and chronic graft-versus-host disease.
Curr Opin Oncol. 1993 Mar;5(2):276-81. doi: 10.1097/00001622-199303000-00005.
10
Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.
J Allergy Clin Immunol. 2000 Jul;106(1 Pt 2):S45-50. doi: 10.1067/mai.2000.106774.
引用本文的文献
1
[Risk factors analysis for steroid-resistant acute graft versus host disease after haploidentical hematopoietic stem cell transplantation].单倍体造血干细胞移植后类固醇难治性急性移植物抗宿主病的危险因素分析
Zhonghua Xue Ye Xue Za Zhi. 2020 Feb 14;41(2):106-111. doi: 10.3760/cma.j.issn.0253-2727.2020.02.004.
本文引用的文献
1
Extra corporeal photochemotherapy in steroid refractory graft versus host disease: A review of guidelines and recommendations.体外光化学疗法治疗类固醇难治性移植物抗宿主病：指南与建议综述
Transfus Apher Sci. 2017 Jun;56(3):376-384. doi: 10.1016/j.transci.2017.01.006. Epub 2017 Feb 16.
2
Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation.间充质基质细胞输注用于治疗造血干细胞移植后类固醇难治性急性移植物抗宿主病III/IV级。
Bone Marrow Transplant. 2017 Jun;52(6):859-862. doi: 10.1038/bmt.2017.35. Epub 2017 Mar 13.
3
Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation.风险分层皮质类固醇预防单倍体移植后急性移植物抗宿主病的对照、随机、开放性试验。
J Clin Oncol. 2016 Jun 1;34(16):1855-63. doi: 10.1200/JCO.2015.63.8817. Epub 2016 Apr 18.
4
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.缓解期 AML 患者接受 HLA 单倍体相合与同胞全相合移植的前瞻性多中心研究
Blood. 2015 Jun 18;125(25):3956-62. doi: 10.1182/blood-2015-02-627786. Epub 2015 May 4.
5
Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).环孢素A、甲氨蝶呤和霉酚酸酯联合预防移植物抗宿主病的多中心II期研究：中国骨髓移植协作组（CBMTCG）的结果
J Hematol Oncol. 2014 Aug 21;7:59. doi: 10.1186/s13045-014-0059-3.
6
Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia.单倍体相合造血干细胞移植作为挽救疗法治疗儿童和青少年获得性重度再生障碍性贫血的良好疗效。
Bone Marrow Transplant. 2014 Dec;49(12):1481-5. doi: 10.1038/bmt.2014.187. Epub 2014 Aug 18.
7
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.异基因造血干细胞移植相关血栓性微血管病的诊断和风险标准：一项针对儿童和青年的研究。
Blood. 2014 Jul 24;124(4):645-53. doi: 10.1182/blood-2014-03-564997. Epub 2014 May 29.
8
Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.单倍体相合移植后标准风险疾病患者中两种不同剂量抗胸腺细胞球蛋白的影响：一项随机试验
Bone Marrow Transplant. 2014 Mar;49(3):426-33. doi: 10.1038/bmt.2013.191. Epub 2013 Dec 2.
9
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.GVHD 的预防和治疗：EBMT-ELN 工作组关于标准化实践的建议。
Bone Marrow Transplant. 2014 Feb;49(2):168-73. doi: 10.1038/bmt.2013.107. Epub 2013 Jul 29.
10
Diagnosis and management of chronic graft-versus-host disease.慢性移植物抗宿主病的诊断和治疗。
Br J Haematol. 2012 Jul;158(1):46-61. doi: 10.1111/j.1365-2141.2012.09128.x. Epub 2012 Apr 26.
Zotero 插件